Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinical Trials
Clinicopathological Conference
Commentary
Corrigendum
Current Issue
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letter to the Editor – Authors’ reply
Letters to Editor
Literature Review
Media & News
Nephrology in India
Notice of Corrigendum
Notice of Retraction
Obituary
Original Article
Patient’s Voice
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinical Trials
Clinicopathological Conference
Commentary
Corrigendum
Current Issue
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letter to the Editor – Authors’ reply
Letters to Editor
Literature Review
Media & News
Nephrology in India
Notice of Corrigendum
Notice of Retraction
Obituary
Original Article
Patient’s Voice
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
View/Download PDF

Translate this page into:

Letter to the Editor
ARTICLE IN PRESS
doi:
10.25259/IJN_820_2025

Alport Syndrome in Older Adults: What is the Evidence?

Department of Medicine, Northampton Healthcare NHS Foundation Trust, Northampton, United Kingdom
Department of Medicine, Manchester University NHS Foundation Trust, Crumpsall, Manchester, United Kingdom
Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom
Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Fulwood, Preston, United Kingdom
Department of Renal Research, Renal Research Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital & The University of Sydney, Sydney, Australia

Corresponding author: Henry HL Wu, Department of Renal Research, Kolling Institute of Medical Research, Royal North Shore Hospital & The University of Sydney, Renal Research Laboratory, Sydney, Australia. E-mail: hon.wu@sydney.edu.au

Licence
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

How to cite this article: Shaban A, Li WC, Chinnadurai R, Ponnusamy A, Wu HHL. Alport Syndrome in Older Adults: What is the Evidence? Indian J Nephrol. doi: 10.25259/IJN_820_2025

Dear Editor,

Alport syndrome (AS) is a hereditary nephropathy, with disease onset typically occurring in childhood or early adulthood. Few reports record cases in which AS was first diagnosed later in life (i.e., age ≥50 years). Initial clinical presentations of AS in older adults may be subtle, lack the classical features, and are hence challenging to diagnose clinically. We identified 11 peer-reviewed publications reporting AS where case individuals were first diagnosed at ages ≥50 years [Table 1].S1-S10

Supplementary References
Table 1: Summary of identified publications describing diagnosed cases of Alport syndrome in older adults
Author(s), year of publication Study design Age at diagnosis (years) Sex Ethnic origin Clinical manifestation Genetic mutation
Khorsan et al.,S1 2025 Case report 78 Male Not specified Persistent hematuria, sensorineural hearing loss, hypertension, and kidney cysts COL4A4 gene (p.Gly408Glu)
Rana et al.,S2 2025 Case report 66 Male Hispanic Proteinuria and rising creatinine COL4A4 gene (c.3022G>A:p.Gly1008Arg)
Hernandez et al.,S3 2023 Case report 62 Female Hispanic Kidney cysts, microscopic hematuria, proteinuria, arthritis, otalgia, and hypertension. COL4A4 gene (c.2794A>T:p.Lys932)
Chen et al.,S4 2023 Case report 59 Female Chinese Microscopic hematuria and proteinuria COL4A3 gene (c.888G>A:p.Gln296Gln)
Rahimzadeh et al.,S5 2023 Case report 50 Female Not specified Edema, microscopic hematuria, and proteinuria (>1g/day). Genetic testing was not performed
Hoefele et al.,S6 2010 Case report on a family (3 members) 13 (son) 46 (father) 70 (paternal grandfather) Male Italian Hematuria and proteinuria. Persistent hematuria and proteinuria. Kidney stones and ESKD (grandfather). COL4A3 gene (p.G291E in exon 15)
Liu and XieS7, 2025 Case report 55 Female Not specified Proteinuria, hematuria, and hypertension COL4A4 gene (c.913G > C:p.Gly305Arg)
Daga et al.,S8 2024 Case report on a family (2 members) 62 64 (maternal cousin) Female Italian Proteinuria and microscopic hematuria COL4A3 gene (c.765G>A:p.Thr255Thr)
- 6 male and 2 female Cypriot Two females and one male were heterozygous carriers. Five affected males reached ESKD. COL4A5 gene (P628L mutation)
- 8 males and 5 females Cypriot Four affected males - two developed ESKD, 2 showed mild kidney impairment. Others had microscopic hematuria
Wilson et al.,S9 2007 Case report on a family (8 members) 32,36,39,39, 41,42,60,64 Male and female New Zealand Two progressed to ESKD Four had CKD, No extrarenal manifestations. COL4A5 gene (c.4913G>A:p.Cys1638Tyr)
Gross et al.,S10 2025 Single-center observational study 45 is the mean age at diagnosis, with numerous patients diagnosed at age ≥ 50 Female 66% Male 34% Mixed Females - less severe involvement. Males with X-linked disease and lower eGFR most likely progress. COL4A5 gene (61.2%) Autosomal dominant (18.2%) Others (20.6%)

Many had long-standing microscopic hematuria and proteinuria attributed to IgA nephropathy,S3-S5 thin basement membrane nephropathy,S6 or hypertension.S1,S4,S7 In several cases, AS was only diagnosed after a progressive decline in kidney function prompted clinical re-evaluation.S1,S3,S5 Some patients were already at CKD stage III–V when AS was confirmed.S1,S7 Majority of the publications involved heterozygous COL4A3 or COL4A4 variants, consistent with autosomal dominant AS.S1-S8 There were also reports of hypomorphic COL4A5 X-linked variants, which occurred in older females with milder AS disease trajectories.S11 Extrarenal disease features varied considerably – in one case, sensorineural hearing loss preceded AS diagnosis by almost a decade,S1 whereas in other cases, sensorineural hearing loss was absent or indistinguishable from age-related changes.S2,S5,S7,S9 Kidney biopsy findings were also heterogeneous, whilst some reports demonstrated characteristic glomerular basement membrane lamellation, others showed only basement membrane thinning or non-specific changes.S2,S3,S7 Nevertheless, in nearly all cases, genetic confirmation (rather than histology alone) established the AS diagnosis and facilitated cascade screening in patient relatives.S1-S5,S7-S9

Considered together, these reports demonstrate that AS may remain undetected well into later adulthood and should be considered in older individuals with persistent haematuria, proteinuria, or unexplained CKD, even in the absence of classic AS features. Earlier recognition and broader use of genetic testing may prevent diagnostic delay, guide management, and support family screening.

Conflicts of interest

There are no conflicts of interest.


Fulltext Views
395

PDF downloads
159
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections